Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy

Addiction

Volumn 105, Issue 9, 2010, Pages 1660-1668

  Killen, Joel D ^a   Fortmann, Stephen P ^a   Murphy Jr , Greer M ^a   Hayward, Chris ^a   Fong, Dalea ^a   Lowenthal, Kimberly ^a   Bryson, Susan W ^a   Killen, Diana T ^a   Schatzberg, Alan F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Nicotine dependence; selegiline; smoking cessation

Indexed keywords

CARBON MONOXIDE; MONOAMINE OXIDASE INHIBITOR; SELEGILINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; KAPLAN MEIER METHOD; MALE; METHODOLOGY; MIDDLE AGED; MOTIVATION; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REGRESSION ANALYSIS; SEX RATIO; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; BEHAVIOR THERAPY; BREATH TESTS; CARBON MONOXIDE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; MOTIVATION; RECURRENCE; REGRESSION ANALYSIS; SELEGILINE; SEX DISTRIBUTION; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955348875     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.03020.x     Document Type: Article

References (47)

1. Killen J. D., Fortmann S. P. Craving is associated with smoking relapse: findings from three prospective studies. Exp Clin Psychopharmacol 1997 5 : 137 142.
2. Shiffman S. The tobacco withdrawal syndrome. In : Krasnegor N. A., editor. Cigarette Smoking as a Dependence Process. NIDA Res Monograph no. 23, Washington, DC : DHEW 1979, p. 158 184.
3. West R. J., Schneider N. Craving for cigarettes. Br J Addict 1987 82 : 407 415.
4. Hafeley W. Biological basis of drug-induced tolerance, rebound, and dependence. Contribution of recent research on benzodiazepines. Pharmacopsychiatry 1986 19 : 353 361.
5. Koob G. F. Drug addiction: the yin and yang of hedonic homeostasis. Neuron 1996 16 : 893 896.
6. Solomon R. L. Drug addiction: an opponent process theory. In : Maser J. D., Seligman M. E. P., editors. Psychopathology: Experimental Models. San Francisco : WH Freeman 1977, p. 124 145.
7. Wikler A. Dynamics of drug dependence. Arch Gen Psychiatry 1973 28 : 611 619.
8. Markou A., Kosten T. R., Koob G. F. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 1998 18 : 135 174.
9. Grenhoff J., Aston-Jones G., Svensson T. H. Nicotinic effects on the firing pattern of mid brain dopamine neurons. Act Physiol Scan 1986 128 : 351 358.
10. Imperato A., Mulas A., Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 1986 132 : 337 338.
11. Mereu G., Yoon K.-W. P., Boi V., Gesesa G. I., Naes L., Westfall T. C. Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol 1987 141 : 395 399.
12. Epping-Jordan M. P., Watkins S. S., Koob G. F., Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature 1998 393 : 76 9.
13. Barrett J. S., Hochadel T. J., Morales R. J., Rohatagi S., DeWitt K. E., Watson S. K. et al. Pharmacokinetics and safety of a selegiline transdermal system relative to single-dose oral administration in the elderly. Am J Ther 1996 3 : 688 698.
14. Fowler J. S., Volkow N. D., Wang G.-J., Pappas N., Logan J., MacGregor R. et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 1996 379 : 733 736. (Pubitemid 26061736)
15. Houtsmiller E. J., Thornton J. A., Stitzer M. L. Effects of selegiline (l-deprenyl) during smoking and short-term abstinence. Psychopharmacology 2002 163 : 213 220.
16. George T. P., Vessoccjo J. C., Termine A., Jatlow P. I., Kosten T. R., O'Malley S. S. A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation. Biol Psychiatry 2003 53 : 136 143.
17. Biberman R., Neumann R., Katzir I., Gerber Y. A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo nicotine skin patch for smoking cessation. Addict 2003 98 : 1403 1407.
18. Kraemer H. C., Frank E., Kupfer D. J. Moderators of treatment outcomes: clinical, research, and policy importance. JAMA 2006 296 : 1286 1289.
19. Fleiss J. L. Statistical Methods for Rates and Proportions. New York : John Wiley 1981.
20. Ossip-Klein D. J., Bigelow G., Curry S., Hall S., Kirkland S. Task Force 1: classification and assessment of smoking behaviour. Proceedings of the National Working Conference on Smoking Relapse. Health Psychol 1986 5 (Suppl 3 11.
21. Bjornsen W., Rand C., Connett J. E., Lindgren P., Nides M., Pope F. et al. Gender differences in smoking cessation after 3 years in the lung health study. Am J Public Health 1995 85 : 223 230.
22. COMMIT Research Group. Community intervention trial for smoking cessation (COMMIT): I. Cohort results from a four-year community intervention. Am J Public Health 1995 85 : 183 192.
23. Gourlay S. G., Forbes A., Marriner T., Pethica D., McNeil J. J. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ 1994 309 : 842 846.
24. Wetter D. W., Kenford S. L., Smith S. S., Fiore M. C., Jorenby D. E., Baker T. B. Gender differences in smoking cessation. J Consult Clin Psychol 1999 67 : 555 562.
25. Killen J. D., Fortmann S. P., Kraemer H. C., Varady A. Do men outperform women in smoking cessation studies? Maybe - but not by much. Exp Clin Psychopharmacol 2002 10 : 295 301.
26. Perkins K. A. Sex differences in nicotine vs. nonnicotine reinforcement as determinants of tobacco smoking. Exp Clin Psychopharmacol 1996 4 : 166 177.
27. Fagerström K. O. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978 3 : 235 241.
28. Killen J. D., Fortmann S. P., Telch M. J., Newman B. Are heavy smokers different from light smokers? A comparison after 48 hours without cigarettes. JAMA 1988 260 : 1581 1585.
29. First M. B., Spitzer R. L., Gibbon M., Williams J. B. W. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC : American Psychiatric Press, Inc. 1996.
30. Radloff L. S. The CES-D scale: a self-report depression scale for research in the general population. App Psychol Meas 1977 1 : 385 401.
31. Gray J. A. Framework for a taxonomy of psychiatric disorder. In : van Grozen S., van de Poll N., Sergeant J. A., editors. Emotions: Essays on Emotion Theory. Hillsdale, NJ : Lawrence Erlbaum Associates, Inc 1993, p. 29 59.
32. Carver C. S., White T. L. Behavioral Inhibition, Behavioral Activation, and Affective Responses to Impending Reward and Punishment: the BIS/BAS Scales. J Person Soc Psychol 1994 2 : 319 333.
33. Kraemer H. C., Blasely C. M. Centring in regression analyses: a strategy to prevent errors in statistical inference. Int J Meth Psychiatry Res 2004 13 : 141 151.
34. Kraemer H. C., Frank E., Kupfer D. J. Moderators of treatment outcomes: clinical, research, and policy importance. JAMA 2006 296 : 1286 1289.
35. Kraemer H. C., Wilson G. T., Fariburn C. G., Agras W. S. Mediators and moderators of treatment effects in randomized clinical trials. Archiv Gen Psychiatry 2002 50 : 877 878.
36. Kozak J., Fagerström K. O., Sawe U. High-dose treatment with the nicotine patch. Int J Smoking Cessation 1995 4 : 26 8.
37. O'Brien C. P., McLellan A. T. Myths about the treatment of addiction. Lancet 1996 347 : 237 240.
38. Fiore M. C., Smith S. S., Jorenby D. E., Baker T. B. The effectiveness of the nicotine patch for smoking cessation. JAMA 1994 271 : 1940 1947.
39. Killen J. D., Fortmann S. P., Schatzberg A. F., Arredondo C. J., Murphy G., Hayward C. et al. Extended cognitive behavior therapy for cigarette smoking cessation. Addiction 2008 103 : 1381 1390.
40. Killen J. D., Fortmann S. P., Murphy G., Hayward C., Arredondo C. J., Cromp D. et al. Efficacy of extended treatment with bupropion for cigarette smoking cessation. J Consult Clin Psychol 2004 74 : 286 294.
41. Blondal T. Controlled trial of nicotine polacrilex gum with supportive measures. Arch Intern Med 1989 149 : 1818 1821.
42. Hughes J. R., Gust S. W., Keenan R. M., Fenwick J. W., Healey M. L. Nicotine vs placebo gum in general medical practice. JAMA 1989 261 : 1300 1305.
43. Sachs D. P. L., Sawe U., Leischow S. J. Effectiveness of a 16hr transdermal nicotine patch in a medical practice setting, without intensive group counseling. Archiv Int Med 1993 153 : 1881 1890.
44. Moye L. A. Random Research. Circulation 2001 1003 : 3150 3153.
45. Yusuf S., Wittes J., Probstfield J. Analysis and interpretation of treatment effects in subgoups of patients in randomized clinical trials. JAMA 1991 266 : 93 8.
46. Pickering A. D., Gray J. A. Dopamine, appetitive reinforcement, and the neuropsychology of human learning: an individual differences approach. In : Eliasz A., Angleitner A., editors. Advances in Research on Temperament. Lengerich, Germany : Pabst Science Publishers 2001, p. 113 149.
47. Franken H. A., Muris P., Georgieva I. Gray's model of personality and addiction. Addict Behav 2006 31 : 399 403.